- Central Florida Division External Communications

At AdventHealth, two such treatments are now being deployed to treat the most seriously ill COVID patients: remdesivir and sarilumab. To receive these medications, patients must be in the intensive care unit and receiving oxygen support.
Given the urgency of the COVID-19 outbreak, the FDA is allowing hospitals to deploy the drugs outside of their officially approved uses. Remdesivir was originally developed to treat the Ebola virus; sarilumab is a treatment for moderate to severe rheumatoid arthritis.
Remdesivir is an antiviral drug that is designed to inhibit virus reproduction. Physicians are seeking to learn if remdesivir’s effects will extend to coronavirus patients too.
AdventHealth, along with leading medical institutions across the country, is administering sarilumab as part of a clinical trial to determine its effectiveness against COVID-19. Its normal function is to reduce inflammation in joints, so the hope is it will have a similar benefit in reducing the inflammatory response in the lungs of severely ill COVID patients.
“It’s very exciting that we are able to offer this trial to patients and determine what the best treatment is going to be for others with this condition,” said Dr. Amay Parikh, site principal investigator for the trial and medical director of the Neuro ICU at AdventHealth Orlando. “Having patients participate is going to help a lot more people across the nation.”
More than 30 patients have been enrolled in the sarilumab trial to date, and more are being sought nationwide.
The remdesivir and sarilumab treatments are part of a broad effort to bring innovative solutions to the fight against COVID-19. AdventHealth has launched a program to collect plasma of patients who’ve recovered from the disease to help those still struggling with the disease.
Recent News
The AdventHealth Orchestra traveled to Washington, D.C., to perform at the Kennedy Center as part of the Capital Orchestra Festival.
For Kay Barnett, leadership goes beyond a job title -- it’s about presence, perseverance and empowering others along the way.
Dr. Sinclair has over 25 years of clinical experience as a practicing physician, including 20 years in progressive leadership roles.
ShorePoint Health Port Charlotte in Port Charlotte, Florida, has joined AdventHealth, one of the largest faith-based health systems in the United States.
This is the first initiative to place AEDs on buses in Orlando and one of the first times the technology has been implemented on public transit in the U.S.
Days before competing in the DAYTONA 500, driver Erik Jones visited a Central Florida elementary school to deliver a big surprise.
Students across seven elementary schools in Kansas received more than 1,500 pairs of new shoes and 3,000 pairs of new socks.
More patients have been helped by an innovative device for stroke survivors at AdventHealth than any other health system in the country.
AdventHealth Centra Care Medical Director Tim Hendrix, MD, explains the symptoms of and the prevention strategies for the "quad-demic" of illnesses going around.
AdventHealth has named Khelsea Bauer president/CEO for AdventHealth DeLand, effective Feb. 23.
AdventHealth has reached a major milestone by welcoming its 100,000th team member to the health system’s skilled and compassionate workforce.
The 3D Motion Lab at AdventHealth Sports Med and Rehab Innovation Tower is the only of its kind in Florida.